Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Fate Therapeutics in San Diego is seeking an Associate Scientist, Quality Control, to execute molecular assays (ddPCR) and DNA/RNA extractions. The role includes cross-training in flow cytometry and cell-based potency methods, building broad technical skills across platforms.
You will contribute to routine investigations, quality event resolution, and continuous improvements while supporting daily QC lab operations in a fast-paced environment at our San Diego headquarters.
Fate Therapeutics is seeking a motivated Associate Scientist to join the Quality Control (QC) team. As an individual contributor in the QC laboratory, the successful candidate will focus primarily on molecular assay execution, including digital droplet PCR (ddPCR), and DNA/RNA extraction. The Associate Scientist, Quality Control will also cross-train in and perform flow cytometry and cell-based potency methods, building a broad technical skill set across multiple platforms. In addition, this role will contribute to routine laboratory investigations, quality event resolution, continuous improvement initiatives, and general laboratory operations, offering meaningful opportunities to shape how the lab runs. This is a full-time, exempt position located at our corporate headquarters in San Diego, CA.
The preceding job description indicates the general nature and level of work performed by employees within this classification. Additional and incidental duties related to the primary duties may be required from time to time.
Fate Therapeutics, Inc. is an equal opportunity employer. We value diversity and are committed to creating an inclusive environment for all employees.
To learn about how Fate collects and uses job application information, please visit Fate's online Privacy Notice.
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered master iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company's pipeline includes iPSC-derived T-cell and natural killer (NK) cell product candidates, which are selectively designed, incorporate novel synthetic controls of cell function, and are intended to deliver multiple therapeutic mechanisms to patients. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.